Skip to main content
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · IEX Real-Time Price · USD
13.58
-0.05 (-0.37%)
At close: Jul 19, 2024, 4:30 PM
13.53
-0.05 (-0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $7.85M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $4.22M. In the year 2023, Stoke Therapeutics had annual revenue of $8.78M.

Revenue (ttm)
$7.85M
Revenue Growth
-46.10%
P/S Ratio
90.22
Revenue / Employee
$71,318
Employees
110
Market Cap
707.80M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.78M-3.63M-29.22%
Dec 31, 202212.41M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Weave Communications 178.08M
Wave Life Sciences 112.91M
Sage Therapeutics 91.06M
Zymeworks 50.46M
Arbutus Biopharma 12.99M
Lexicon Pharmaceuticals 2.31M
Revenue Rankings

STOK News

More News